Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LGALS3 | P17931 | 13/20 | 0.57 |
| ▸ | LGALS9 | O00182 | 5/20 | 0.57 |
| ▸ | LGALS1 | P09382 | 5/20 | 0.57 |
| ▸ | LGALS7; LGALS7B | P47929 | 4/20 | 0.56 |
| ▸ | SSTR4 | P31391 | 2/20 | 0.46 |
| ▸ | SSTR5 | P35346 | 2/20 | 0.46 |
| ▸ | LGALS8 | O00214 | 3/20 | 0.45 |
| ▸ | LGALS4 | P56470 | 3/20 | 0.43 |
| ▸ | CA12 | O43570 | 1/20 | 0.40 |
| ▸ | CA1 | P00915 | 1/20 | 0.40 |
| ▸ | CA2 | P00918 | 1/20 | 0.40 |
| ▸ | CA4 | P22748 | 1/20 | 0.40 |
| ▸ | CA5A | P35218 | 1/20 | 0.40 |
| ▸ | CA7 | P43166 | 1/20 | 0.40 |
| ▸ | CA5B | Q9Y2D0 | 1/20 | 0.40 |
| ▸ | MAOB | P27338 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3817822 | 0.90 | LGALS3 (0.65) | LGALS3LGALS9LGALS1LGALS7; LGALS7BSSTR4 | |
| SCHEMBL19674440 | 0.88 | LGALS3 (0.58) | LGALS3LGALS9LGALS1LGALS7; LGALS7BSSTR4 | |
| SCHEMBL19674473 | 0.88 | LGALS3 (0.58) | LGALS3LGALS9LGALS1LGALS7; LGALS7BSSTR4 | |
| SCHEMBL12642964 | 0.86 | LGALS9 (0.51) | LGALS3LGALS9LGALS1LGALS7; LGALS7BSSTR4 | |
| SCHEMBL16329927 | 0.86 | LGALS9 (0.51) | LGALS3LGALS9LGALS1LGALS7; LGALS7BSSTR4 | |
| SCHEMBL14885828 | 0.86 | LGALS3 (0.46) | LGALS3LGALS9LGALS1SSTR4SSTR5 | |
| SCHEMBL17309342 | 0.85 | LGALS3 (0.57) | LGALS3LGALS9LGALS1LGALS7; LGALS7BSSTR4 | |
| SCHEMBL17154133 | 0.84 | LGALS3 (0.60) | LGALS3LGALS9LGALS1LGALS7; LGALS7BSSTR4 | |
| SCHEMBL17154143 | 0.84 | LGALS3 (0.60) | LGALS3LGALS9LGALS1LGALS7; LGALS7BSSTR4 | |
| SCHEMBL5899337 | 0.84 | LGALS3 (0.56) | LGALS3LGALS9LGALS1LGALS7; LGALS7BSSTR4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2857411-B1 | METHOD FOR PREPARING FULLY PROTECTION HEPARIN PENTASACCHARIDE AND INTERMEDIATE THEREOF | ZHEJIANG HISUN PHARM CO LTD (CN) | 2017-12-06 | — | — | EP | disclosed |
| US-20150284419-A1 | METHOD FOR PREPARING FULLY PROTECTION HEPARIN PENTASACCHARIDE AND INTERMEDIATE THEREOF | ZHEJIANG HISUN PHARMACEUTICAL CO., LTD. (CN) | 2015-10-08 | — | — | US | disclosed |
| EP-2857411-A1 | METHOD FOR PREPARING FULLY PROTECTION HEPARIN PENTASACCHARIDE AND INTERMEDIATE THEREOF | Zhejiang Hisun Pharmaceutical Co. Ltd. (CN) | 2015-04-08 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20150284419-A1 | METHOD FOR PREPARING FULLY PROTECTION HEPARIN PENTASACCHARIDE AND INTERMEDIATE THEREOF | HABP2, HPSE, PLG | LGALS3 2783/4885LGALS9 2377/4885LGALS1 3570/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.